SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-009844
Filing Date
2023-03-30
Accepted
2023-03-30 17:18:18
Documents
78
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2257845
2 ex14.htm EX-14 91934
3 ex23-1.htm EX-23.1 3672
4 ex31-1.htm EX-31.1 11865
5 ex31-2.htm EX-31.2 11976
6 ex32-1.htm EX-32.1 4817
7 ex32-2.htm EX-32.2 4757
  Complete submission text file 0001493152-23-009844.txt   8795057

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ensc-20221231.xsd EX-101.SCH 55756
9 XBRL CALCULATION FILE ensc-20221231_cal.xml EX-101.CAL 74986
10 XBRL DEFINITION FILE ensc-20221231_def.xml EX-101.DEF 302974
11 XBRL LABEL FILE ensc-20221231_lab.xml EX-101.LAB 511364
12 XBRL PRESENTATION FILE ensc-20221231_pre.xml EX-101.PRE 415318
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1148109
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38306 | Film No.: 23781804
SIC: 2834 Pharmaceutical Preparations